开放获取期刊获得更多读者和引用
700 种期刊 和 15,000,000 名读者 每份期刊 获得 25,000 多名读者
Marco Mirijello
The ineffectiveness of antimicrobial drugs, especially antibiotics, represents one of the most pressing challenges for global health. In 2019, 1.27 million people died from common bacterial infections that had become antibioticresistant, underscoring the need for a global response. This article examines the dimensions of the problem, identifies challenges in pharmaceutical innovation, emphasizes the importance of financial incentives, and highlights the crucial role of global health authorities in combating antimicrobial drug ineffectiveness.